Oncolytic Virus Therapy Market - Global Outlook and Forecast 2021-2027

Oncolytic Virus Therapy Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Oncolytic Virus Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncolytic Virus Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncolytic Virus Therapy Overall Market Size
2.1 Global Oncolytic Virus Therapy Market Size: 2021 VS 2027
2.2 Global Oncolytic Virus Therapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncolytic Virus Therapy Players in Global Market
3.2 Top Global Oncolytic Virus Therapy Companies Ranked by Revenue
3.3 Global Oncolytic Virus Therapy Revenue by Companies
3.4 Top 3 and Top 5 Oncolytic Virus Therapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Oncolytic Virus Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncolytic Virus Therapy Players in Global Market
3.6.1 List of Global Tier 1 Oncolytic Virus Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncolytic Virus Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncolytic Virus Therapy Market Size Markets, 2021 & 2027
4.1.2 HSV-based Oncolytic Viruses
4.1.3 Adenoviruses-based Oncolytic Viruses
4.1.4 Vaccinia Virus-based Oncolytic Viruses
4.1.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
4.1.6 Newcastle Disease Virus-based Oncolytic Viruses
4.2 By Type - Global Oncolytic Virus Therapy Revenue & Forecasts
4.2.1 By Type - Global Oncolytic Virus Therapy Revenue, 2016-2021
4.2.2 By Type - Global Oncolytic Virus Therapy Revenue, 2022-2027
4.2.3 By Type - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncolytic Virus Therapy Market Size, 2021 & 2027
5.1.2 Melanoma
5.1.3 Prostate Cancer
5.1.4 Breast Cancer
5.1.5 Ovarian Cancer
5.1.6 Others
5.2 By Application - Global Oncolytic Virus Therapy Revenue & Forecasts
5.2.1 By Application - Global Oncolytic Virus Therapy Revenue, 2016-2021
5.2.2 By Application - Global Oncolytic Virus Therapy Revenue, 2022-2027
5.2.3 By Application - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Oncolytic Virus Therapy Market Size, 2021 & 2027
6.2 By Region - Global Oncolytic Virus Therapy Revenue & Forecasts
6.2.1 By Region - Global Oncolytic Virus Therapy Revenue, 2016-2021
6.2.2 By Region - Global Oncolytic Virus Therapy Revenue, 2022-2027
6.2.3 By Region - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Oncolytic Virus Therapy Revenue, 2016-2027
6.3.2 US Oncolytic Virus Therapy Market Size, 2016-2027
6.3.3 Canada Oncolytic Virus Therapy Market Size, 2016-2027
6.3.4 Mexico Oncolytic Virus Therapy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Oncolytic Virus Therapy Revenue, 2016-2027
6.4.2 Germany Oncolytic Virus Therapy Market Size, 2016-2027
6.4.3 France Oncolytic Virus Therapy Market Size, 2016-2027
6.4.4 U.K. Oncolytic Virus Therapy Market Size, 2016-2027
6.4.5 Italy Oncolytic Virus Therapy Market Size, 2016-2027
6.4.6 Russia Oncolytic Virus Therapy Market Size, 2016-2027
6.4.7 Nordic Countries Oncolytic Virus Therapy Market Size, 2016-2027
6.4.8 Benelux Oncolytic Virus Therapy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Oncolytic Virus Therapy Revenue, 2016-2027
6.5.2 China Oncolytic Virus Therapy Market Size, 2016-2027
6.5.3 Japan Oncolytic Virus Therapy Market Size, 2016-2027
6.5.4 South Korea Oncolytic Virus Therapy Market Size, 2016-2027
6.5.5 Southeast Asia Oncolytic Virus Therapy Market Size, 2016-2027
6.5.6 India Oncolytic Virus Therapy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Oncolytic Virus Therapy Revenue, 2016-2027
6.6.2 Brazil Oncolytic Virus Therapy Market Size, 2016-2027
6.6.3 Argentina Oncolytic Virus Therapy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncolytic Virus Therapy Revenue, 2016-2027
6.7.2 Turkey Oncolytic Virus Therapy Market Size, 2016-2027
6.7.3 Israel Oncolytic Virus Therapy Market Size, 2016-2027
6.7.4 Saudi Arabia Oncolytic Virus Therapy Market Size, 2016-2027
6.7.5 UAE Oncolytic Virus Therapy Market Size, 2016-2027
7 Players Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Oncolytic Virus Therapy Major Product Offerings
7.1.4 Amgen Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.1.5 Amgen Key News
7.2 Oncolytics Biotech
7.2.1 Oncolytics Biotech Corporate Summary
7.2.2 Oncolytics Biotech Business Overview
7.2.3 Oncolytics Biotech Oncolytic Virus Therapy Major Product Offerings
7.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.2.5 Oncolytics Biotech Key News
7.3 Viralytics
7.3.1 Viralytics Corporate Summary
7.3.2 Viralytics Business Overview
7.3.3 Viralytics Oncolytic Virus Therapy Major Product Offerings
7.3.4 Viralytics Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.3.5 Viralytics Key News
7.4 Transgene SA
7.4.1 Transgene SA Corporate Summary
7.4.2 Transgene SA Business Overview
7.4.3 Transgene SA Oncolytic Virus Therapy Major Product Offerings
7.4.4 Transgene SA Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.4.5 Transgene SA Key News
7.5 Oncolys BioPharma
7.5.1 Oncolys BioPharma Corporate Summary
7.5.2 Oncolys BioPharma Business Overview
7.5.3 Oncolys BioPharma Oncolytic Virus Therapy Major Product Offerings
7.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.5.5 Oncolys BioPharma Key News
7.6 Targovax
7.6.1 Targovax Corporate Summary
7.6.2 Targovax Business Overview
7.6.3 Targovax Oncolytic Virus Therapy Major Product Offerings
7.6.4 Targovax Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.6.5 Targovax Key News
7.7 PsiOxus Therapeutics
7.7.1 PsiOxus Therapeutics Corporate Summary
7.7.2 PsiOxus Therapeutics Business Overview
7.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Major Product Offerings
7.4.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.7.5 PsiOxus Therapeutics Key News
7.8 SillaJen Biotherapeutics
7.8.1 SillaJen Biotherapeutics Corporate Summary
7.8.2 SillaJen Biotherapeutics Business Overview
7.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Major Product Offerings
7.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.8.5 SillaJen Biotherapeutics Key News
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Corporate Summary
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Major Product Offerings
7.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.9.5 Sorrento Therapeutics Key News
7.10 Lokon Pharma
7.10.1 Lokon Pharma Corporate Summary
7.10.2 Lokon Pharma Business Overview
7.10.3 Lokon Pharma Oncolytic Virus Therapy Major Product Offerings
7.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.10.5 Lokon Pharma Key News
7.11 Genelux Corporation
7.11.1 Genelux Corporation Corporate Summary
7.11.2 Genelux Corporation Business Overview
7.11.3 Genelux Corporation Oncolytic Virus Therapy Major Product Offerings
7.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.11.5 Genelux Corporation Key News
7.12 Vyriad
7.12.1 Vyriad Corporate Summary
7.12.2 Vyriad Business Overview
7.12.3 Vyriad Oncolytic Virus Therapy Major Product Offerings
7.12.4 Vyriad Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.12.5 Vyriad Key News
7.13 TILT Biotherapeutics
7.13.1 TILT Biotherapeutics Corporate Summary
7.13.2 TILT Biotherapeutics Business Overview
7.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Major Product Offerings
7.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.13.5 TILT Biotherapeutics Key News
7.14 Cold Genesys
7.14.1 Cold Genesys Corporate Summary
7.14.2 Cold Genesys Business Overview
7.14.3 Cold Genesys Oncolytic Virus Therapy Major Product Offerings
7.14.4 Cold Genesys Oncolytic Virus Therapy Revenue in Global (2016-2021)
7.14.5 Cold Genesys Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Oncolytic Virus Therapy Market Opportunities & Trends in Global Market
Table 2. Oncolytic Virus Therapy Market Drivers in Global Market
Table 3. Oncolytic Virus Therapy Market Restraints in Global Market
Table 4. Key Players of Oncolytic Virus Therapy in Global Market
Table 5. Top Oncolytic Virus Therapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Oncolytic Virus Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Oncolytic Virus Therapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Oncolytic Virus Therapy Product Type
Table 9. List of Global Tier 1 Oncolytic Virus Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncolytic Virus Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Oncolytic Virus Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Oncolytic Virus Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Oncolytic Virus Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Oncolytic Virus Therapy Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Oncolytic Virus Therapy Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Oncolytic Virus Therapy Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Oncolytic Virus Therapy Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Oncolytic Virus Therapy Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Oncolytic Virus Therapy Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Oncolytic Virus Therapy Revenue, (US$, Mn), 2022-2027
Table 30. Amgen Corporate Summary
Table 31. Amgen Oncolytic Virus Therapy Product Offerings
Table 32. Amgen Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 33. Oncolytics Biotech Corporate Summary
Table 34. Oncolytics Biotech Oncolytic Virus Therapy Product Offerings
Table 35. Oncolytics Biotech Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 36. Viralytics Corporate Summary
Table 37. Viralytics Oncolytic Virus Therapy Product Offerings
Table 38. Viralytics Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 39. Transgene SA Corporate Summary
Table 40. Transgene SA Oncolytic Virus Therapy Product Offerings
Table 41. Transgene SA Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 42. Oncolys BioPharma Corporate Summary
Table 43. Oncolys BioPharma Oncolytic Virus Therapy Product Offerings
Table 44. Oncolys BioPharma Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 45. Targovax Corporate Summary
Table 46. Targovax Oncolytic Virus Therapy Product Offerings
Table 47. Targovax Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 48. PsiOxus Therapeutics Corporate Summary
Table 49. PsiOxus Therapeutics Oncolytic Virus Therapy Product Offerings
Table 50. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 51. SillaJen Biotherapeutics Corporate Summary
Table 52. SillaJen Biotherapeutics Oncolytic Virus Therapy Product Offerings
Table 53. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 54. Sorrento Therapeutics Corporate Summary
Table 55. Sorrento Therapeutics Oncolytic Virus Therapy Product Offerings
Table 56. Sorrento Therapeutics Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 57. Lokon Pharma Corporate Summary
Table 58. Lokon Pharma Oncolytic Virus Therapy Product Offerings
Table 59. Lokon Pharma Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 60. Genelux Corporation Corporate Summary
Table 61. Genelux Corporation Oncolytic Virus Therapy Product Offerings
Table 62. Genelux Corporation Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 63. Vyriad Corporate Summary
Table 64. Vyriad Oncolytic Virus Therapy Product Offerings
Table 65. Vyriad Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 66. TILT Biotherapeutics Corporate Summary
Table 67. TILT Biotherapeutics Oncolytic Virus Therapy Product Offerings
Table 68. TILT Biotherapeutics Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 69. Cold Genesys Corporate Summary
Table 70. Cold Genesys Oncolytic Virus Therapy Product Offerings
Table 71. Cold Genesys Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Oncolytic Virus Therapy Segment by Type
Figure 2. Oncolytic Virus Therapy Segment by Application
Figure 3. Global Oncolytic Virus Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Oncolytic Virus Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Oncolytic Virus Therapy Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2020
Figure 8. By Type - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 9. By Application - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 10. By Region - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 11. By Country - North America Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 12. US Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 16. Germany Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 17. France Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 24. China Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 28. India Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 30. Brazil Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 33. Turkey Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 37. Amgen Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Oncolytics Biotech Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Viralytics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Transgene SA Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Oncolys BioPharma Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Targovax Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sorrento Therapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Lokon Pharma Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Genelux Corporation Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Vyriad Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. TILT Biotherapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs